SCHEMBL30394978

SCHEMBL30394978

COc1ccc(CO)cc1C(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 1/20 0.46
▸ MTNR1B P49286 1/20 0.46
▸ LMNA P02545 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.40
▸ HTT P42858 2/20 0.40
▸ MRGPRX4 Q96LA9 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ LDHA P00338 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ TTR P02766 1/20 0.39
▸ KMT2A Q03164 1/20 0.38
▸ ABCG2 Q9UNQ0 1/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31135565 0.87 MTNR1A (0.45) MTNR1AMTNR1BLMNAHPGDKDM4E
SCHEMBL16355875 0.87 MTNR1A (0.45) MTNR1AMTNR1BLMNAHPGDKDM4E
SCHEMBL22733403 0.85 CFD (0.52) MTNR1AMTNR1BLMNAHPGDKDM4E
SCHEMBL31371288 0.84 HPGD (0.56) LMNAHPGDKDM4EHTTALDH1A1
SCHEMBL4155356 0.84 HPGD (0.56) LMNAHPGDKDM4EHTTALDH1A1
SCHEMBL19655515 0.82 ALOX15 (0.48) MTNR1AMTNR1BCA12CA2CA3
SCHEMBL30206724 0.82 ALOX15 (0.48) MTNR1AMTNR1BCA12CA2CA3
SCHEMBL31588004 0.81 EGFR (0.51) KDM4EALDH1A1PPARACA12CA2
SCHEMBL16355746 0.81 ACHE (0.47) MTNR1AMTNR1BLMNAHPGDKDM4E
SCHEMBL30394858 0.80 MTNR1A (0.38) MTNR1AMTNR1BLMNAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250268903-A1 RXFP1 AGONISTS BRISTOL MYERS SQUIBB CO (US) 2025-08-28 — — US disclosed
EP-4423058-A1 RXFP1 AGONISTS Bristol-Myers Squibb Company (US) 2024-09-04 — — EP disclosed
CN-118451058-A RXFP1 agonists 百时美施贵宝公司 2024-08-06 — — CN disclosed
WO-2023077040-A1 RXFP1 AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250268903-A1 RXFP1 AGONISTS RXFP1, RXFP2, RXFP3 MTNR1A 169/4885MTNR1B 145/4885LMNA 3685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback